The 8 Best Reasons To Invest In Psychedelic Stocks

Acute need. Huge markets. A wide-open playing field. Those are some of the best reasons to invest in psychedelic drug stocks.

Read more
U.S. Supreme Court Refuses to Hear Landmark Cannabis Case
On Tuesday, the U.S. Supreme Court refused to hear a prominent case, Washington v. Barr, which argued that cannabis prohibition is unconstitutional. This action in effect upholds an earlier district court ruling which said that the plaintiffs – who included a former NFL player, a veteran, pediatric cannabis patients... Read more
Medcolcanna Organics Inc. Announces Listing on The NEO Exchange And Delisting of Common Shares From The TSXV
Ryan Allway October 14th, 2020 Uncategorized BOGOTÁ, Colombia, Oct. 13, 2020 (GLOBE NEWSWIRE) — Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that, further to its press release dated September 25, 2020, the Company will... Read more
How Religious Groups Can Petition to Use Psychedelics Legally

I recently wrote a post outlining the long history of religious exemptions to the federal Controlled Substances Act (CSA). In this post, I’ll provide a brief overview of the hoops that religious organizations have to jump through. Religious organizations that want to use psychedelics for religious purposes and comply with U.S. law are forced to […]

The post How Religious Groups Can Petition to Use Psychedelics Legally appeared first on Harris Bricken.

Read more
Mind Cure Announces Addition of Neuroscientist Dr. Wolfram Tetzlaff to Scientific Advisory Board

Mind Cure adds an expert in neuroscience and nutrition to its Advisory Board.

Read more
New Jersey Voters Overwhelmingly Support Legalization

New Jersey voters support cannabis legalization in the state by a two-to-one margin, according to an Farleigh Dickson University poll released October 9.

Read more
Pharmather (CSE:PHRM) Is The Latest Psychedelics IPO

The newest psychedelics company plans to focus on both ketamine- and psilocybin-assisted psychedelics R&D.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )